How do I become a peptide reseller?

You become a peptide reseller by doing four things in roughly this order: form a real business entity and open business banking under it, have an attorney review how you intend to describe, label, and sell what you carry, open a wholesale account with a supplier whose batch testing you can independently verify, and then build your listings, labels, and internal records so that research-use-only framing holds up everywhere a customer or a processor might look. The sourcing step is where most new brands stumble — not because supply is hard to find, but because a supplier who won't show you a batch-matched certificate of analysis before you place an order has already told you what your product documentation is going to look like after you place one. Real Peptides operates a Wholesale Partner Program built for this buyer: businesses stocking research peptides for resale. Everything below is general information for business planning, not legal advice.

The setup work that comes before your first order

The administrative layer is unglamorous and it is also the part that decides whether you can operate at all. Start with entity formation and a federal tax ID, because almost nothing downstream works without them — wholesale accounts, resale exemption paperwork, merchant underwriting, and business insurance all key off a registered entity rather than a person.

Most states operate some form of resale or seller's permit that lets a reseller purchase inventory without paying sales tax at the point of purchase, then collect at the point of sale. The mechanics, the name of the document, and the filing cadence differ, so treat that as a question for your state's revenue department and your accountant rather than something a supplier can answer for you. Suppliers can tell you what documentation they need on file; they cannot tell you what your state requires of you.

Payment processing deserves attention earlier than new brands usually give it. This product category tends to draw extra scrutiny during merchant underwriting, and processors commonly ask to see your website copy, your product pages, your refund policy, and your substantiation for any claim you make. A store that describes compounds in therapeutic terms is a store that invites a hard underwriting conversation. A store that keeps its listings squarely research-use-only, with no dosing language and no outcome promises, gives underwriting far less to argue with. Build the copy that way from day one rather than rewriting it after an account gets flagged.

Then there are the quiet operational pieces: business insurance, a storage plan that matches how the material ships and is meant to be held, a lot-tracking method so that every unit you sell can be traced back to a specific batch and its documentation, and a written policy for what happens if a customer reports a problem with a lot. None of that is exciting. All of it is what separates a brand from a dropship page.

The legal questions belong with your attorney, not your supplier

The honest position on licensing is that it is a question, not a settled fact — and any supplier who tells you otherwise is selling you certainty they cannot actually deliver. Regulatory treatment of research chemicals varies by jurisdiction, by compound, by how the product is described, and by who you sell it to. That combination means the useful thing is not an answer from an article; it is a list of questions to put in front of counsel who practices in this area.

The questions worth bringing: How should my entity be registered, and does my state require any permit or registration for what I intend to distribute? What restrictions apply to how I describe these compounds in marketing, on labels, and in customer communications? What customer categories can I sell to, and what verification, if any, should I perform and document? What record-keeping should I maintain per batch and per order? What do my supplier's terms say about who bears responsibility for downstream representations? If I ship across state or national borders, what changes?

A related point: research-use-only material is not for human or animal use, and your listings should say so plainly. If a customer or a channel partner raises a question about administration to an animal, that is a conversation for a licensed veterinarian — not something your customer service inbox should be answering, and not something a supplier's catalog page can resolve.

None of this is legal advice, and no article should be your compliance program. Budget for a few hours of a qualified attorney's time before you launch. It is cheaper than the alternative and it makes every later decision — copy, packaging, channel, insurance — faster to make.

How wholesale tiers and minimums actually work

Wholesale pricing in this category is almost always tiered, and the tiers exist for a structural reason rather than an arbitrary one. Peptide production runs at the batch level: synthesis, purification, lyophilization, fill, and analytical testing are largely fixed costs spread across whatever quantity that batch yields. A larger commitment spreads those fixed costs across more units, which is why per-unit pricing falls as volume rises. Minimum order quantities exist for the same reason — below a certain size, the batch-level testing and fulfillment cost simply doesn't amortize.

Tiers are typically structured either per order or against cumulative volume over a period. The difference matters more than the headline price. A per-order tier rewards larger, less frequent purchases and ties up working capital in inventory. A cumulative tier rewards consistency and lets you order smaller quantities more often while still earning the better rate. Ask which model a supplier uses before you model your cash flow, because the same nominal discount produces very different capital requirements under each.

Margins vary widely with volume, compound category, freight, breakage, and how you position the brand, and anyone who quotes you a specific spread without seeing your cost structure is guessing. What you can control is landed cost clarity. Landed cost is the unit price plus shipping, plus any cold-chain or handling surcharge, plus the cost of capital sitting in inventory, plus your realistic expectation for damaged or unsellable units. A supplier who publishes tier pricing plainly lets you build that model. A supplier who hides everything behind "contact us for a quote" makes you build a business plan around a number you do not have — and that opacity is frequently where the margin quietly goes.

One more mechanic: reorder lead time drives how much inventory you must hold. Fast, predictable domestic fulfillment lets you run leaner and reorder on a tighter cycle. Long or unpredictable lead times force you to carry buffer stock, which is capital you do not get to spend on marketing.

Reading a certificate of analysis like a buyer

The certificate of analysis is the single most useful diligence document available to you, and most new resellers read it wrong. A purity percentage on its own is a headline, not a picture. Purity by HPLC tells you what proportion of the material is the intended compound; it does not confirm the compound's identity, and it does not tell you what else is present.

Depending on the compound and the laboratory, broader analytical panels can cover identity confirmation by mass spectrometry, purity by HPLC, water content, counterion or residual acid content, residual solvents, and bacterial endotoxin. Each of these answers a different question, and a supplier who runs a multi-panel program is answering more of them than a supplier who reports a single number.

Here is the practical checklist when you evaluate any supplier's documentation. Is the COA tied to a specific lot or batch number, and does that number match what arrives on your unit? Is the testing laboratory identified, and is it independent of the seller? Is there a report date? Does the document show the actual analytical output, or only a summary table someone could have typed? Is the COA available to you before you buy, or produced only on request — or worse, sold as a paid add-on? That last practice is common enough in this industry to be worth naming, and it should tell you something. Documentation you have to purchase separately is documentation the seller does not consider part of the product.

Verify one lot yourself before you commit to a program. Pull the COA, match the lot number, read the panels, and confirm that what the marketing page claims is what the analytical report shows. If those two things disagree, no pricing tier makes the relationship worth it.

White label, private label, or stocking a supplier's label

New brands generally choose among three sourcing models, and the right one depends on how much brand control you need versus how much operational load you can absorb.

The practical difference between white label and private label is who defines the product. White label means you put your identity on something the manufacturer already makes and already tests. Private label means the run is made to your specification, which gives you differentiation and also gives you responsibility for that specification. Both require you to keep batch documentation attached to your lots, because your customers will ask, and your own brand name is now the one on the vial.

What Real Peptides does differently

Real Peptides supplies research-use-only peptides to businesses through its Wholesale Partner Program, and the program is built around documentation you can check rather than claims you have to accept.

Material is produced to 99%+ HPLC purity and every batch goes through 6-panel testing. The certificates of analysis are publicly verifiable — a prospective partner can look at the lab results directly, before applying, without paying for the privilege and without a sales conversation gating access. That is deliberate, and it is the opposite of the paid-COA and quote-only patterns that make this category hard to shop.

Fulfillment is handled domestically with orders shipping in 5–7 days, which matters for the inventory math described above: predictable lead times let a reseller reorder on a tighter cycle instead of parking capital in buffer stock. And the application to become a wholesale partner is a 3-step process rather than an extended qualification gauntlet.

What the program does not do is equally worth stating. Compounds are supplied for research use only. They are not FDA-approved drugs, they are not described as therapeutics, and no dosing, administration, or outcome guidance is provided — not to partners and not to their customers. If a supplier is willing to hand you human-use language, that willingness is a liability transferring quietly onto your entity.

Where to go from here

If you have an entity, a plan for how you will describe what you sell, and counsel who has reviewed it, the remaining decision is which supplier's documentation you are prepared to stand behind. Read a COA, match a lot, compare it against the marketing, and then talk pricing tiers. Businesses that clear that bar and want to stock research peptides can submit an application to the Wholesale Partner Program and get tier pricing and fulfillment terms in writing before committing to anything.

For more detail on how tiers, minimums, and onboarding work, see the wholesale peptides program overview and the wholesale peptides guide, or apply for a wholesale account to start the three-step process.